RESUMO
Objective To observe the clinical effect and security of autohemotherapy combined with bacillus calmette-guerin polysaccharide and nucleic acid in treatment of facial steroid-dependent dermatitis.Methods The 74 patients with facial steroid-dependent dermatitis were divided into treatment group (38patients) and control group (36 patients) according to the treatment method.The patients in treatment group were treated with autohemotherapy combined with bacillus calmette-gnerin polysaccharide and nucleic acid 1 ml muscle injection,every 3 days a time for 4 weeks.The patients in control group were treated with bacillus calmette-guerin polysaccharide and nucleic acid,every 3 days a time for 4 weeks.The effect was compared between the two groups.Results The total effective rate in treatment group was 84.2％(32/38),in control group was 63.9％(23/36),there was significant difference between the two groups (P ＜ 0.05).No serious adverse reaction was found in two groups.Conclusion Autohemotherapy combined with bacillus calmettegnerin polysaccharide and nucleic acid is safe and effective in treatment of facial steroid-dependent dermatitis.
RESUMO
Objective To investigate the clinical efficacy of ganciclovir combined with Bacillus Calmette-Guerin polysaccharide nucleic acid (BCG-PSN) for the treatment of herpes zoster. Methods Eighty-six cases with herpes zoster were randomly divided into study group and control group, 43 cases in each group. Patients of control group received simple ganciclovir treatment; while patients of the study group received BCG-PSN on this basis, then to observe and compare the efficacy, the repair time of skin lesions (herpes stopping, surface deposition), odynolysis time, remained neuralgia incidence and adverse reactions of two groups. Results Patients of two groups all completed the experiment successfully, no one withdraw from this trial because of no tolerance of drugs. The herpes stopping and surface deposition time and odynolysis time of study group were significantly shorter than those of control group, the difference was statistically significant (P＜0.05 ); the remained neuralgia incidence was significantly lower than that of control group,the difference was statistically significant (P＜0.05); the effective rate of study group in 14 days after treatment was 90.7% (39/43) and significantly higher than that of control group [74.4% (32/43)], the difference was statistically significant (P ＜ 0.05);there were no serious adverse reactions occurred in two groups. Conclusion Application of ganciclovir combined with BCG-PSN for the treatment of herpes zoster has certain efficacy, it is feasible and safe.